CCM2 and cerebral cavernous malformation: 2007). Around 20% of familial CCM result from CCM2 gene mutations leading to functional loss (de Vos et al. 2017). Patients with CCM2 mutations often experience fewer clinical symptoms and present with a less severe phenotype compared to those with other CCM gene mutations (Denier et al. 2006).